BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6894416)

  • 1. Calcitriol dosage in osteomalacia, hypoparathyroidism and attempted treatment of myositis ossificans progressiva.
    Stamp TC
    Curr Med Res Opin; 1981; 7(5):316-36. PubMed ID: 6894416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic use of vitamin D, its derivatives and their analogs].
    Vagneur JP; Argemi B
    Diabete Metab; 1982 Mar; 8(1):65-7. PubMed ID: 6980150
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitriol in disorders of bone and calcium metabolism.
    Riggs BL
    Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
    [No Abstract]   [Full Text] [Related]  

  • 5. Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial.
    Saha S; Sreenivas V; Goswami R
    J Clin Endocrinol Metab; 2021 Jun; 106(7):2092-2102. PubMed ID: 33616655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
    Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
    Weisbrode SE
    Am J Pathol; 1981 Jul; 104(1):35-40. PubMed ID: 6266257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
    Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
    Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoparathyroidism during pregnancy: treatment with calcitriol.
    Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommended for use in various bone diseases: therapy with a vitamin D metabolite].
    MMW Munch Med Wochenschr; 1979 Aug; 121(34):1062. PubMed ID: 114759
    [No Abstract]   [Full Text] [Related]  

  • 12. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
    Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
    N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia.
    Hodsman AB; Wong EG; Sherrard DJ; Brickman AS; Lee DB; Singer FR; Norman AW; Coburn JW
    Am J Med; 1983 Mar; 74(3):407-14. PubMed ID: 6338716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy with vitamin D and D-metabolites].
    Flury W; Haldimann B
    Schweiz Med Wochenschr; 1981 Feb; 111(9):314-21. PubMed ID: 6261326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
    Okano K; Furukawa Y; Morii H; Fujita T
    J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology and therapeutic use of vitamin D and its analogues.
    Pierides AM
    Drugs; 1981 Apr; 21(4):241-56. PubMed ID: 6262039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vitamin D metabolites in the pathogenesis and management of osteoporosis.
    Crilly RG; Horseman A; Peacock M; Nordin BE
    Curr Med Res Opin; 1981; 7(5):337-48. PubMed ID: 6894417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism.
    Epstein S; Meunier PJ; Lambert PW; Stern PH; Bell NH
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):241-7. PubMed ID: 6687971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response to 1,25-dihydroxycholecalciferol and to dihydrotachysterol in adult-onset hypophosphataemic osteomalacia.
    Ahmed KY; Varghese Z; Moorhead JF; Wills MR
    Clin Chim Acta; 1979 Sep; 97(1):33-7. PubMed ID: 315284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.